KAYLIE TRAM: Open Payments
NPI 1346842853 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,387 in 70 payments from 18 companies in 2025. Trend: 2023 $2,514 · 2024 $2,003 · 2025 $1,387
Food & beverage: $1,387
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $180 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $172 |
| Otsuka America Pharmaceutical, Inc. | 9 | $172 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $161 |
| Alkermes, Inc. | 5 | $121 |
| Janssen Pharmaceuticals, Inc | 4 | $107 |
| Lundbeck LLC | 4 | $87 |
| Axsome Therapeutics, Inc. | 4 | $82 |
| Collegium Pharmaceutical, Inc. | 3 | $74 |
| Teva Pharmaceuticals USA, Inc. | 2 | $45 |
Products named: REXULTI, VRAYLAR, TRINTELLIX, CAPLYTA, ARISTADA, Auvelity, Jornay PM, INVEGA SUSTENNA.
Industry payments across NC — which companies pay providers there.
